Schlapbach, L.J., Andre, M.C., Grazioli, S., Schöbi, N., Ritz, N., et al. (2021) Best Practice Recommendations for the Diagnosis and Management of Children with Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland. Frontiers in Pediatrics, 9, Article 667507.
https://doi.org/10.3389/fped.2021.667507

has been cited by the following article:

• TITLE: Pediatric Inflammatory Multisystem Syndrome; Unusual Presentation of COVID-19 in Children: About Thirty Cases

  AUTHORS: Fatima-Ezzahra Tahiri, Karima El Fakiri, Nourredine Rada, Ghizlaine Draiss, Nadia El Idrissi Slitine, Mounir Bourrous, Said Younous, Mohammed Bouskraoui

  KEYWORDS: COVID-19, Inflammation, Kawasaki Like, Myocarditis, Immunoglobulins

  JOURNAL NAME: Open Journal of Pediatrics, Vol.13 No.1, January 11, 2023

  ABSTRACT: Pediatric inflammatory multisystem syndrome PIMS is a new entity of systemic inflammatory disease in children that appeared in the epidemic context of COVID-19 infection in April 2020. The pathophysiological mechanisms of PIMS are poorly understood and the hypothesis of a maladaptive hyperactive immune response, notably involving cytokines, is described in the literature. In our study, we report our experience regarding the clinical presentation, diagnosis, management and outcome of patients who presented with pediatric inflammatory multisystem syndrome post COVID-19.